Advertisement
Screener

GUARDANT HEALTH, INC. (GH) ROA

Guardant Health, Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Guardant Health, Inc. roa for the quarter ending 2025-03-31 was -30.99%, a change of -3.95% year-over-year.
  • Guardant Health, Inc. roa for the quarter ending 2024-12-31 was -29.37%, a change of -2.53% year-over-year.
  • Guardant Health, Inc. roa for the quarter ending 2024-09-30 was -33.30%, a change of -9.25% year-over-year.
  • Guardant Health, Inc. roa for the quarter ending 2024-06-30 was -30.49%, a change of -2.87% year-over-year.
  • Guardant Health, Inc. roa for fiscal 2025 was -20.67%, a change of 8.70% from fiscal 2024.
  • Guardant Health, Inc. roa for fiscal 2024 was -29.37%, a change of -2.53% from fiscal 2023.
  • Guardant Health, Inc. roa for fiscal 2023 was -26.84%, a change of 13.82% from fiscal 2022.
  • Guardant Health, Inc. roa for fiscal 2022 was -40.66%, a change of -23.20% from fiscal 2021.
Available history
2017-12-31 to 2025-12-31
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2025-03-31-30.99%-$416.55M-$95.16M$1.34B
2024-12-31-29.37%-$436.37M-$111.03M$1.49B
2024-09-30-33.30%-$512.41M-$107.75M$1.54B
2024-06-30-30.49%-$490.76M-$102.63M$1.61B
2024-03-31-27.04%-$460.9M-$114.98M$1.7B
2023-12-31-26.84%-$479.45M-$186.99M$1.79B
2023-09-30-24.06%-$432.34M-$86.10M$1.8B
2023-06-30-27.62%-$508.23M-$72.77M$1.84B
2023-03-31-43.99%-$664.89M-$133.53M$1.51B
2022-12-31-40.66%-$654.59M-$139.95M$1.61B
2022-09-30-34.49%-$586.97M-$161.99M$1.7B
2022-06-30-28.73%-$532.5M-$229.43M$1.85B
2022-03-31-18.81%-$400.64M-$123.23M$2.13B
2021-12-31-17.45%-$384.77M$2.2B
2021-09-30-18.22%-$405.5M$2.23B
2021-06-30-16.13%-$369.65M$2.29B
2021-03-31-13.71%-$321.81M$2.35B
2020-12-31-10.84%-$246.28M$2.27B
2020-09-30-13.89%-$175.35M$1.26B
2020-06-30-9.14%-$116.77M$1.28B
2020-03-31-8.26%-$78.33M$948.17M
2019-12-31-7.05%-$67.85M$962.54M
2019-09-30-7.49%-$71.01M$948.33M
2019-06-30-8.66%-$81.43M$939.99M
2019-03-31-15.85%-$91.77M$579.17M
2018-12-31-14.35%-$84.26M-$25.12M$587.4M
2018-09-30-21.49%-$74.05M-$24.46M$344.6M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-20.67%-$416.28M$2.01B
2024-12-31-29.37%-$436.37M$1.49B
2023-12-31-26.84%-$479.45M$1.79B
2022-12-31-40.66%-$654.59M$1.61B
2021-12-31-17.45%-$384.77M$2.2B
2019-12-31-7.86%-$75.65M$962.54M
2018-12-31-14.48%-$85.06M$587.4M
2017-12-31-24.27%-$83.22M$342.94M

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30